Quotient Ltd.

Quotient Ltd.

Quotient Ltd.

Overview
Date Founded

2012

Headquarters

B1, Business Park Terre Bonne, Route de Crassier 13, Eysins, 1262, CHE

Type of Company

Public

Employees (Worldwide)

418

Industries

Biotechnology
Hospitals & Patient Services
Pharmaceuticals

Company Description

Quotient Ltd. is a commercial-stage diagnostics company. It provides immunohematology products to hospitals and blood banks. The firm develops, manufactures and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. The company was founded on January 18, 2012 and is headquartered in Eysins, Switzerland.

Contact Data
Trying to get in touch with decision makers at Quotient Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Financial Officer

Chief Operating Officer

Chief Commercial Officer

Principal Accounting Officer & Head of Financial Accounting & Treasury

Professional

Professional

Professional

Professional

Professional

Paths to Quotient Ltd.
Potential Connections via
Relationship Science
You
Quotient Ltd.
Owners & Shareholders
Details Hidden

Founded in 1999, Perceptive Advisors focuses on supporting progress in the life sciences industry by identifying opportunities and directing financial resources toward the most promising technologies in modern healthcare. Today, the firm manages approximately $7.3 billion across our strategies.

Details Hidden

HCM seeks to generate attractive risk-adjusted returns by offering credit-focused solutions across a range of liquidity and investment profiles, including hedge funds, drawdown vehicles and co-investments. Portfolio construction and allocation decisions are made using sophisticated quantitative models, as well as, traditional qualitative analysis. They focus on relative value strategies with idiosyncratic sources of return. The firm combines a diverse set of world class investment strategies, dynamic capital allocation and rigorous risk management seeking to generate consistent alpha-driven returns.

Details Hidden

Pura Vida Investments focuses on long/short equity investments in the healthcare and wellness sectors.

Recent Transactions
Details Hidden

Quotient Ltd. issued . USD Ordinary Shares

Details Hidden

Quotient Ltd. issued USD Ordinary Shares

Details Hidden

Quotient Ltd. raised money in a private placement transaction

Transaction Advisors
Escrow Agent

Advised onQuotient Ltd. issued . USD Ordinary Shares

Legal Advisor

Advised onQuotient Ltd. issued . USD Ordinary Shares

Legal Advisor

Advised onQuotient Ltd. issued . USD Ordinary Shares

Global Joint Head of Pharmaceuticals & Life

Advised onQuotient Ltd. issued USD Ordinary Shares

Managing Director, Health Care Investment Banking Group

Advised onQuotient Ltd. issued . USD Ordinary Shares

Underwriter

Advised onQuotient Ltd. issued USD Ordinary Shares

Advisors & Consultants
Advisor

Chief Executive Officer at Quotient Bioscience Ltd.

Clients

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.

Key Stats and Financials As of 2020
Market Capitalization
$496M
Total Enterprise Value
$360M
Earnings Per Share
$-1.44
Three Year Compounded Annual Growth Rate Of Revenue
13.68%
Debt TEV
0.55x
TEVNet Income
-3.5x
Enterprise Value / Sales
11.03x
Total Equity
$-5.53M
Total Debt
$198M
EBITDAMargin
-215.63%
EBITDA
$-70.4M
Net Profit
$-103M
Revenue
$32.7M
Investors
Details Hidden

Managing Partner at IQ Capital Partners LLP

Details Hidden

Galen Collaborative Capital focuses exclusively on investments in the healthcare sector including healthcare technology-enabled services, healthcare information technology, medical devices and specialty pharmaceutical companies. The firm seeks to make mid- to late-stage investments in healthcare companies that have achieved scale in traditional and emerging growth segments. Galen looks to invest in proprietary products or services that have attained a revenue run-rate greater than $10 million and that have near-term prospects for positive cash flow. Galen typically invests in convertible preferred equity securities with an initial placement of at least $10 million. Investments typically range from $10 million to $30 million, but Galen will invest in syndicate in transactions up to $100 million. The firm's growth-oriented portfolio offers limited partners direct investment opportunities in privately placed equity, mezzanine debt and senior debt

Suppliers
Merck KGaA Hospitals & Patient Services | Darmstadt, Germany

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate & Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Stratec SE Industrial Machinery & Manufacturing | Birkenfeld, Germany

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.

Diagast SAS Holding Companies | Loos, France

DIAGAST SAS operates as a blood matching company. Its products include QWALYS range, Erythrocytes Magnetized technology, manual range, PK 7300 ranges, pre-transfusion control, disposable plates and technical inserts. The company was founded in 1968 and is headquartered in Loos, France.

Competitors
Danaher Corporation Industrial Machinery & Manufacturing - Washington, DC

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Bio-Rad Laboratories Inc. Industrial Machinery & Manufacturing - Hercules, CA

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Quotient Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Quotient Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Quotient Ltd..